Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2016 5
2017 3
2018 3
2019 2
2020 7
2021 12
2022 6
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Intraductal papillary growth of metastatic colorectal cancer.
Kudo S, Matsuki R, Shibahara J, Sakamoto Y. Kudo S, et al. Among authors: matsuki r. Jpn J Clin Oncol. 2024 Feb 7;54(2):225-226. doi: 10.1093/jjco/hyad153. Jpn J Clin Oncol. 2024. PMID: 37967167 No abstract available.
A multicenter validation study for determining the condition of nonanatomical or minor anatomical hepatectomies satisfying technical difficulty of current high-level hepatectomy certificated by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Matsuki R, Sakamoto Y, Yoshida M, Ogiso S, Soyama A, Seki Y, Tokumitsu Y, Eguchi S, Hasegawa K, Nagano H, Kokudo N, Hatano E. Matsuki R, et al. J Hepatobiliary Pancreat Sci. 2023 Nov;30(11):1218-1226. doi: 10.1002/jhbp.1372. Epub 2023 Oct 5. J Hepatobiliary Pancreat Sci. 2023. PMID: 37798934
Development of conversion therapy for advanced hepatocellular carcinoma.
Matsuki R, Kogure M, Hasui N, Momose H, Suzuki Y, Sakamoto Y. Matsuki R, et al. Hepatobiliary Surg Nutr. 2023 Jun 1;12(3):453-456. doi: 10.21037/hbsn-23-204. Epub 2023 May 10. Hepatobiliary Surg Nutr. 2023. PMID: 37351138 Free PMC article. No abstract available.
Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression.
Matsuki R, Okano N, Hasui N, Kawaguchi S, Momose H, Kitahama K, Nagahama K, Kogure M, Suzuki Y, Nagashima F, Shibahara J, Mori H, Sakamoto Y. Matsuki R, et al. Liver Cancer. 2022 Oct 25;12(2):180-183. doi: 10.1159/000527250. eCollection 2023 Jun. Liver Cancer. 2022. PMID: 37325496 Free PMC article. No abstract available.
A Prospective Study of Neoadjuvant Gemcitabine Plus Nab-paclitaxel in Patients with Borderline-resectable Pancreatic Cancer.
Okano N, Matsuki R, Toki M, Gondo K, Ochiai K, Watanabe S, Tateishi H, Kogure M, Suzuki Y, Sugiyama M, Nagashima F, Shibahara J, Sakamoto Y, Furuse J. Okano N, et al. Among authors: matsuki r. Intern Med. 2023 Feb 1;62(3):327-334. doi: 10.2169/internalmedicine.9504-22. Epub 2022 Jul 5. Intern Med. 2023. PMID: 35793961 Free PMC article.
35 results